Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Some birth control pills have a higher risk of blood clots than others.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Human hair follicle stem cells help repair tendon injuries.

More precise, personalized therapies are needed for autoimmune diseases.

CD4+ skin cells may be precursors to basal cell carcinoma.

SCD1 inhibitors can cause skin issues in rodents.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

A circular RNA helps cashmere goat hair cells become hair follicles by blocking a molecule to boost a gene important for hair growth.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

PTEN helps control the number and health of skin stem cells by working with the protein BMAL1.

Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The editorial welcomes the new editor of JCAS and discusses the journal's focus on quality research, global reach, and commitment to free access.

The article explains how to rebuild parts of the head and face and how to transplant hair to cover scars, highlighting the need for careful planning and choosing the right method for each patient.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Finasteride helped treat a 28-year-old's facial skin condition.

The YH complex, made from Astragalus membranaceus and Cinnamomum cassia, may help treat hair loss by promoting hair growth and follicle development.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.